Ditchcarbon
  • Contact
  1. Organizations
  2. CollPlant
Public Profile
Pharmaceutical Preparation Manufacturing
IL
updated a month ago

CollPlant Sustainability Profile

Company website

CollPlant Biotechnologies Ltd., headquartered in Israel, is a pioneering company in the regenerative medicine and tissue engineering sectors. Founded in 2004, CollPlant has made significant strides in developing innovative solutions for wound healing and organ regeneration, leveraging its proprietary recombinant human collagen technology. The company’s core products include advanced wound care solutions and potential therapeutic applications for various medical conditions. What sets CollPlant apart is its unique ability to produce collagen through a plant-based system, ensuring a sustainable and biocompatible alternative to animal-derived collagen. With a strong market position, CollPlant has garnered attention for its groundbreaking research and development efforts, positioning itself as a leader in the biotechnology industry. Its commitment to enhancing patient outcomes through cutting-edge technology continues to drive its growth and influence in the field.

DitchCarbon Score

How does CollPlant's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

CollPlant's score of 25 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.

37%

Let us know if this data was useful to you

CollPlant's reported carbon emissions

In 2023, CollPlant Biotechnologies Ltd., headquartered in Israel (IL), reported total carbon emissions of approximately 457,636.4 kg CO2e, comprising 74,588.2 kg CO2e from Scope 1 and 383,048.2 kg CO2e from Scope 2 emissions. This marks a slight increase from 2022, where total emissions were about 439,930.0 kg CO2e, with Scope 1 at 71,860.0 kg CO2e and Scope 2 at 368,070.0 kg CO2e. In 2021, the company recorded total emissions of approximately 405,592.7 kg CO2e, indicating a trend of rising emissions over the past three years. CollPlant has not disclosed any Scope 3 emissions data, nor has it set specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The company’s emissions data is not cascaded from any parent organization, indicating that these figures are independently reported. Overall, while CollPlant has made strides in transparency regarding its emissions, the absence of reduction commitments highlights an area for potential improvement in its climate strategy.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202120222023
Scope 1
62,137.8
00,000
00,000.0
Scope 2
343,454.9
000,000
000,000.0
Scope 3
-
-
-

How Carbon Intensive is CollPlant's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. CollPlant's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is CollPlant's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for CollPlant is in IL, which has a low grid carbon intensity relative to other regions.

CollPlant's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

CollPlant has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare CollPlant's Emissions with Industry Peers

Mentor Worldwide LLC

US
•
Health and social work services (85)
Updated 2 months ago

Humabiologics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

Sinclair Pharma Limited

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

MDW

US
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Acelity L.P. Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251119.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy